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The full-length human immunodeficiency virus type 1 (HIV-1) mRNA encodes two precursor polyproteins,
Gag and GagProPol. An infrequent ribosomal frameshifting event allows these proteins to be synthesized from
the same mRNA in a predetermined ratio of 20 Gag proteins for each GagProPol. The RNA frameshift signal
consists of a slippery sequence and a hairpin stem-loop whose thermodynamic stability has been shown in in
vitro translation systems to be critical to frameshifting efficiency. In this study we examined the frameshift
region of HIV-1, investigating the effects of altering stem-loop stability in the context of the complete viral
genome and assessing the role of the Gag spacer peptide p1 and the GagProPol transframe (TF) protein that
are encoded in this region. By creating a series of frameshift region mutants that systematically altered the
stability of the frameshift stem-loop and the protein sequences of the p1 spacer peptide and TF protein, we have
demonstrated the importance of stem-loop thermodynamic stability in frameshifting efficiency and viral
infectivity. Multiple changes to the amino acid sequence of p1 resulted in altered protein processing, reduced
genomic RNA dimer stability, and abolished viral infectivity. The role of the two highly conserved proline
residues in p1 (position 7 and 13) was also investigated. Replacement of the two proline residues by leucines
resulted in mutants with altered protein processing and reduced genomic RNA dimer stability that were also
noninfectious. The unique ability of proline to confer conformational constraints on a peptide suggests that the
correct folding of p1 may be important for viral function.
Human immunodeficiency virus type 1 (HIV-1) uses a 1
ribosomal frameshifting event that enables the precursor
polyproteins Gag and Pol to be synthesized from the same
genomic mRNA (for reviews, see references 19 and 24). The
gag gene has its own distinct initiation and termination codons.
The pol gene, however, lacks an initiation codon. Conse-
quently, since pol partially overlaps and is in the 1 reading
frame with respect to the gag gene, it is synthesized only as part
of a GagProPol fusion protein (19, 20, 33, 42) (Fig. 1A). The
frameshift required for the translation of GagProPol is pro-
moted by an RNA signal comprising a “slippery” sequence (U
UUU UUA), a 7-nucleotide spacer region, and a hairpin stem-
loop (Fig. 1B). The stem-loop has been described as a simple
RNA loop structure (19, 24, 30); however, recent work by
Dinman et al (10) led them to predict that the RNA secondary
structure required for efficient frameshifting may be a more
complex triple-helix stem-loop. The 1 ribosomal frameshift-
ing utilized by HIV-1 is thought to occur because ribosomes
traveling along the mRNA translating gag interact with the
stem-loop and as a result are temporarily stalled on the slip-
pery sequence (19, 22, 38). While paused, approximately 1 in
20 ribosomes slip back 1 nucleotide, ensuring that Gag and
GagProPol are synthesized in a strict ratio of 20 Gag molecules
to each GagProPol (20). The ratio of Gag to GagProPol is
critical for viral assembly and replication (18, 23, 29, 37).
The kinetics of ribosomal pausing at the frameshift signal
are very precise. While the slippery sequence alone mediates a
low level of frameshifting, the presence of the stem-loop in-
creases the ribosomal frameshifting efficiency three- to fivefold
(3, 5, 6, 30, 34). Bidou et al. (3) showed that mutations which
decreased stem-loop thermodynamic stability also decreased
the frequency of frameshifting events while increased stem-
loop stability had a negative effect on frameshifting efficiency.
Rather than using a stem-loop that maximizes frameshifting
efficiency, it appears that the virus favors a stem-loop that
supports the correct ratio of Gag to GagProPol synthesis. This
is reflected in the great natural variation in the stability of the
frameshift stem-loop among 76 gag nucleotide sequences from
various strains and subtypes of HIV-1 examined by Chang et
al. (7). For example, the average estimated thermodynamic
stability (G) of the frameshift stem-loops from 29 subtype B
viruses was 21.3 kcal/mol while that of 9 subtype A stem-
loops was 17 kcal/mol and 5 of 7 subtype F sequences had an
estimated stability of less than or equal to 15 kcal/mol (7).
The critical RNA secondary structure of the frameshift sig-
nal and the open reading frames for two proteins (p1 from Gag
and the transframe protein [TF] from GagProPol) overlap
(Fig. 1A). Accordingly, when mutations are introduced into
the stem-loop RNA structure of the frameshift signal, the
protein sequences of p1 and TF are also altered. The spacer
peptide p1 is a 16-amino-acid protein to which no function has
yet been ascribed. TF consists of two domains: a conserved
N-terminal octapeptide (TFP) and a 48- to 60-amino-acid vari-
able region (P6Pol) that are separated by a cleavage site (4, 25).
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While there is abundant evidence to suggest that TF is involved
in the regulation of protease (PR) activity (1, 25, 32, 41, 43, 44),
the mechanism of regulation remains unclear. TF-deleted mu-
tants have enhanced polyprotein processing in vitro (25, 31),
suggesting that the autocatalytic release of PR from TF acts as
a triggering event for proteolytic processing (26, 31). Further-
more, cleavage of TF from PR is crucial for the stabilization of
the PR dimeric structure (27), and Paulus et al. (32) have
demonstrated that recombinant TF inhibits mature PR activity
in vitro, suggesting an additional function for TF as a negative
regulator of PR.
We have examined the frameshift region of HIV-1 to assess
the effects of altering stem-loop stability in the context of the
complete viral genome and to determine the roles of p1 and
TF in HIV-1 replication. To isolate the RNA frameshift signal
from p1 and TF, we have used a mutagenesis strategy which
alters stem-loop stability and the amino acid sequences of p1
and TF independently. Mutants with a large decrease in stem-
loop stability were found to be noninfectious, demonstrating
the importance of stem-loop stability and frameshifting effi-
ciency to viral replication. Mutations altering only TF, while
preserving p1 sequence and stem-loop stability, did not affect
virion function. However, changes to the amino acid sequence
of p1, which retained the TF sequence and stem-loop stability,
altered the virion and intracellular HIV-1 protein profiles and
reduced the stability of genomic RNA dimers. In addition,
these virions were noninfectious in peripheral blood mononu-
clear cells (PBMCs). Two additional p1 mutants were created
to further examine the importance of p1 for HIV-1 replication.
Replacement of the two highly conserved proline residues (po-
sitions 7 and 13) in p1 with leucines (P1:pro), destroyed
infectivity, altered protein profiles, and reduced genomic RNA
dimer stability. The P1:pro mutant, which was designed to
emulate the SLP1TF mutations while keeping the two proline
residues intact (P1:pro), displayed reduced infectivity but
had protein profiles similar to wild-type profiles and had un-
changed genomic RNA dimer stability. This study provides the
first evidence that p1 and its two highly conserved proline
residues are important for HIV-1 replication.
MATERIALS AND METHODS
Construction of DNA plasmids. The HIV-1 DNA constructs used in this study
were derived from the full-length wild-type HIV-1 plasmid HXB2-BH10 (40).
Mutations were introduced into the region between DNA nucleotides nt 2096
FIG. 1. (A) Schematic representation of the Gag and GagProPol polyproteins, showing the major domains and the stem-loop, p1, and TF
overlapping region. (B) Wild-type frameshift coding region from HXB2-BH10.
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and 2128 of HXB2-BH10 (5-GATCTGGCCTTCCTACAAGGGAAGGCCAG
GGAA -3) which includes the frameshift stem-loop (SL) and encodes the p1
and TF proteins (Fig. 1A). Four initial frameshift region mutants have been
named such that an asterisk indicates when an alteration has been made to SL,
p1, or TF, with the wild-type being SLP1TF. Two additional p1 mutants were also
created, P1:pro and P1:pro. All mutants were created using PCR stitch
mutagenesis to introduce mutations via the PCR primers, as previously described
(17), and subsequent cloning into HXB2-BH10 via the restriction sites ApaI and
BclI. The resultant mutants are as depicted in Table 1, with the changes indicated
in italics. The thermodynamic stability of the predicted stem-loop structures for
each of the mutants was determined with the mfold program by M. Zuker of
Washington University School of Medicine (12, 21, 35) using the server located
at The Macfarlane Burnet Institute for Medical Research and Public Health
(http://mfold.burnet.edu.au/) (Table 1). The SLP1TF mutations were also intro-
duced into the protease-defective SVC21 P() plasmid (16, 28) and are referred
to as P/SLP1TF, P/SLP1TF, P/SLP1TF, and P/SLP1TF. All con-
structs were sequenced to confirm the presence of the desired mutations and the
absence of spontaneous mutations introduced via PCR mutagenesis.
Virus production. The calcium phosphate coprecipitation method was used for
the transient transfection of 293T cells. DNA (10 g) from each of the HIV-1
constructs was routinely used for transfection. The enhanced green fluorescent
protein (EGFP; Clonetech) reporter plasmid (2 g) was added to the DNA
mixture to determine the transfection efficiency. Supernatants and cells were
collected at 36 h posttransfection and separated by centrifugation for 30 min at
3,000 rpm (Beckman model GS-6 centrifuge). The reverse transcriptase (RT)
activity of cell culture supernatants was measured by a micro RT assay as
previously described (15).
Protein isolation and Western blot analysis. Intracellular viral protein was
isolated from transfected 293T cells by washing the cells twice with 1 Tris-
buffered saline (TBS) and then lysing them with 2 TBS lysis buffer containing
1% Nonidet P-40, 20 mM phenylmethylsulfonyl fluoride, 1 M pepstatin, and 1
M leupeptin. Cell lysates were freeze-thawed in liquid nitrogen and then clar-
ified by centrifugation for 20 min at 14,000 rpm (Eppendorf 5417R centrifuge).
The transfection efficiency of the samples was monitored by measuring EGFP
production from the reporter plasmid with a Bio Imaging Analyzer (Fuji Photo
Film Co.). Virion protein was obtained by ultracentrifugation (Beckman model
L-90, SW 41 rotor) of the transfection supernatants at 35,000 rpm for 1 h at 4°C
through a 20% sucrose cushion. The viral pellets were resuspended in 50 l of
2 TBS lysis buffer. Western blot analysis was carried out as previously described
(37), using pooled sera from HIV-1-infected patients to detect total HIV-1 viral
proteins.
Immunoprecipitation of protease-negative samples. Intracellular viral protein
was isolated from transfected 293T cells as described above, with lysis by RIPA
buffer (300 mM NaCl, 50 mM Tris [pH 7.4], 0.5% [vol/vol] Triton x-100, 1 M
pepstatin, 1 M leupeptin, 1 M Pefabloc). The cellular protein was normalized
on the basis of EGFP expression. Pooled sera from HIV-1-infected patients was
added for incubation overnight at 4°C. Sepharose-G beads (Amersham Pharma-
cia Biotech) were then added, and incubation was continued for a further 6 h.
The beads were washed five times with 500 l of RIPA buffer, resuspended in 15
l of sample buffer (100 mM Tris [pH 6.8], 3% sodium dodecyl sulfate [SDS],
33% glycerol, 0.03% bromophenol blue), and heated at 95°C for 10 min for
Western blot analysis using an anti-p24 monoclonal antibody (NEN).
Analysis of virion RNA dimerization. Viral supernatants were purified and
concentrated by ultracentrifugation as described above. Virion pellets were re-
suspended in 500 l of dimerization buffer (10 mM Tris [pH 7.5], 1 mM EDTA,
1% SDS, 50 mM NaCl), phenol-chloroform extracted and isolated for melting-
curve analysis as previously described (13, 14). Similar amounts of genomic RNA
were used to analyze the stability of the virion RNA dimer as previously de-
scribed (37). Briefly, RNA samples that had been heat denatured for 10 min at
the indicated temperatures were separated by electrophoresis in a 1% native
agarose gel in 0.5 Tris-borate-EDTA buffer. Samples were transferred onto a
Hybond N membrane (Amersham Pharmacia Biotech). Dimeric and monomeric
RNAs were hybridized with a radioactive riboprobe (pGEM7zHIV-1), which is
complementary to the 5 end of the HIV-1 genomic RNA.
Infectivity assays. Viral infectivity was measured using the 50% tissue culture
infective dose (TCID 50) method (8). Briefly, PBMCs were isolated from HIV-
seronegative buffy coats (supplied by the Red Cross Blood Bank, Melbourne,
Victoria, Australia) as previously described (8). The PBMCs were stimulated
with 10 g of phytohemagglutinin (Murex Diagnostics) per ml and maintained
for 3 days in RPMI 1640 medium (Gibco) containing 10% fetal bovine serum,
TABLE 1. Mutations within the frameshift region of wild-type HIV-1 (HXB2-BH10)
Construct DNA and protein sequence changesa Energy (G, kcal/mol)b
Ile Trp Pro Ser Tyr Lys Gly Arg Pro Gly
SLP1TF (WT) GATCTGGCCTTCCTACAAGGGAAGGCCAGGGAA 21.4
Asp Leu Ala Phe Leu Gln Gly Lys Ala Arg Glu
Thr Trp Leu Phe Tyr Lys Glu Lys Leu Gly
SLP1TF GACCTGGCTTTTCTACAAGGAAAAGCTAGGGAA 17.4
Asp Leu Ala Phe Leu Gln Gly Lys Ala Arg Glu
Ile Trp Pro Ser Tyr Lys Gly Arg Pro Gly
SLP1TF GATTTGGCCGTCTTACAAAGGGCGGCCGGGGAA 16.2
Asp Leu Ala Val Leu Gln Arg Ala Ala Gly Glu
Thr Ser Arg Ser Tyr Lys Ala Lys Pro Ala
SLP1TF GACCTCGCGTTCTTACAAGGCAAAGCCCGCGAA 6.4
Asp Leu Ala Phe Leu Gln Gly Lys Ala Arg Glu
Ile Trp Pro Ser Tyr Lys Gly Arg Pro Gly
SLP1TF GATATGGCCCAGTTACAAAGGGCGCCCAGGGAA 7.1
Asp Met Ala Gln Leu Arg Ala Pro Arg Glu
Thr Trp Pro Phe Tyr Lys Glu Gly Pro Gly
P1:pro GACCTGGCCTTTCTACAAGGAAGGGCCAGGGAA 21.2
Asp Leu Ala Phe Leu Gln Gly Arg Ala Arg Glu
Ile Trp Leu Ser Tyr Lys Gly Arg Leu Gly
P1:pro GATCTGGCTTTCCTACAAGGGAAGGCTAGGGAA 16.9
Asp Leu Ala Phe Leu Gln Gly Lys Ala Arg Glu
a The upper amino acid sequence is that of p1, while the lower is that of TF. Mutated bases or amino acids are shown in italics; the stem region (Fig. 1) is underlined.
b The thermodynamic stability (G) of each stem-loop structure was estimated using the mfold program by M. Zuker of Washington University School of Medicine
(12, 21, 35) using the server located at The Macfarlane Burnet Institute for Medical Research and Public Health (http://mfold.burnet.edu.au/).
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gentamicin, glutamine, and 5% interleukin-2 (Boehringer). Viral supernatants,
which were normalised for RT activity, were then mixed with 10 5 PBMCs in a
96-well tissue culture plate. Eight 10-fold dilutions of each virus were tested in
triplicate. Viral infectivity was assessed by monitoring RT activity, as described
above, with supernatants collected on days 3, 7, 10, and 14 postinfection.
RESULTS
Mutation of the frameshift region of HIV-1. The critical
RNA secondary structure of the frameshift signal and the open
reading frames for the p1 and TF proteins overlap (Fig. 1A).
We have created two classes of mutations, those that have a
conservative effect on stem-loop stability (SL) and those that
have a dramatic effect on stem-loop stability (SL). Within
these classes are two mutants, one that alters the protein se-
quence of p1 (P1) and one that alters the protein sequence of
TF (TF) (Table 1).
Three main factors influence the stability, and thus the
frameshifting efficiency, of the stem-loop: A-U as opposed to
G-C base pairing, alteration of the total number of base pairs,
and alteration of the sequence of the actual loop (3). For each
of the mutants described here, the 4-bp loop sequence remains
wild type (Fig. 1; Table 1). The wild-type (HXB2-BH10) stem-
loop has seven G-C and three A-U pairs (estimated G 
21.1 kcal/mol1). For the two mutants with a conservative
effect on stem-loop stability, SLP1TF (estimated G 
17.4 kcal/mol1) and SLP1TF (estimated G  16.2
kcal/mol1), only the number of A-U versus G-C pairs was
altered and the estimated G was only 4 to 5 kcal/mol1 more
than that of the wild type. For the two SL mutants, SLP1TF
(estimated G6.4 kcal/mol1) and SLP1TF (estimated
G  7.1 kcal/mol1), stem-loop stability was altered to an
estimated G of 14 to 15 kcal/mol1 more than that of the
wild type by reducing base pairing.
The thermodynamic stability of the frameshift stem-loop is
important for GagProPol expression. Protease-defective con-
structs that lack the ability to process the precursor proteins
into their components were used to evaluate the relationship
between the altered stem-loop stability of the mutants and
frameshifting efficiency, as measured by Pr160-GagProPol syn-
thesis. Comparing the amount of GagProPol synthesized rela-
tive to Pr55-Gag, the mutants with conservative alterations to
stem-loop stability, P/SLP1TF and P/SLP1TF, synthe-
sized GagProPol at a level comparable to that of the wild type
(Fig. 2, lanes 2 and 3). As expected, the synthesis of GagProPol
in the two mutants with major alterations to stem-loop stabil-
ity, P/SLP1TF and P/SLP1TF, was greatly decreased
compared to that in the wild type (Fig. 2, lanes 4 and 5).
Mutants with reduced stem-loop stability or altered p1
amino acid sequences have defective cellular and viral protein
patterns. The HIV-1 proteins detected in cell lysates for each
of the mutants were very similar to those of wild-type virus,
with Pr55-Gag, p24-CA and Pr160-GagProPol/GP160-Env all
being readily identified (Fig. 3A). In most cases, the levels of
proteins synthesized from the mutant virion were comparable
to those obtained from cells transfected with wild-type DNA
(Fig. 3A, lane 1). The most obvious difference was a decrease
in the p66-RT protein levels present in SLP1TF and the two
stem-loop mutants SLP1TF and SLP1TF (lanes 2, 4, and
5 respectively). Purified viral particles derived from cotrans-
fected cells were also analyzed by Western blotting. For similar
levels of p24-CA, the protein profile of SLP1TF was compa-
rable to that of the wild type whereas SLP1TF, SLP1TF,
and SLP1TF showed decreased levels of p66-RT, p51-RT,
and p32-IN when compared to those in the wild type (Fig. 3B).
Mutants with altered p1 amino acid sequences display de-
creased genomic RNA dimer stability. Dimeric RNA was pres-
ent in all viruses (Fig. 4). Wild-type genomic virion RNA started
dissociating from dimeric to monomeric RNA at 45°C. The
stability of the SLP1TF dimeric RNA was dramatically re-
duced (Fig. 4), with some monomeric RNA being detectable
even without heat treatment and only monomeric RNA pres-
ent at 45°C. SLP1TF dimer RNA stability was also compro-
mised, with monomeric RNA being clearly visible at 35°C (Fig
4). RNA isolated from SLP1TF and SLP1TF more closely
resembled wild-type dimeric RNA stability.
Mutants with reduced stem-loop stability or altered p1
amino acid sequences are noninfectious in PBMCs. Wild-type
and mutant virions derived from transfected 293T cells were
normalized for RT activity and assayed for infectivity in PB-
MCs. Infectivity was determined in four different PBMC do-
nors, and Fig. 5 is representative of the replication kinetics
observed in these assays. The mutant with alterations only to
the TF protein sequence (SLP1TF) replicated at a level sim-
ilar to that of wild type, while the p1 mutant (SLP1TF) and
the two mutants with large decreases in stem-loop stability
(SLP1TF and SLP1TF) were noninfectious (Fig. 5).
Proline residues in p1 are important for HIV-1 function. P1
has two proline residues (positions 7 and 13), which are both
altered in SLP1TF. We chose to investigate these residues be-
cause proline has a cyclic structure capable of strongly influ-
encing protein architecture and these proline residues are
highly conserved among different strains of HIV-1. In addition,
the p1-P6 Gag region is rich in this amino acid, which is sur-
prising in a virus where proline residues are relatively uncom-
mon (11). Two additional p1 mutants were created. The first
mutant, P1:pro, has the two proline residues of p1 (positions
7 and 13) replaced by leucines. The predicted stem-loop sta-
bility of this mutant of 21.2 kcal/mol was very similar to that
of the wild type (21.4 kcal/mol) (Table 1). The second mu-
tant, P1:pro, was designed to closely emulate the SLP1TF
mutations while keeping the two proline residues intact. To
FIG. 2. Impact of frameshift region mutations on HIV-1 Gag-
ProPol expression. Cell lysates from transfections of 293T cells with
protease-defective constructs were immunoprecipitated with sera from
HIV-1-infected patients and then assayed by Western blot analysis
using an anti-P24 antibody. Lane 1 shows the wild-type (P/SLP1TF)
profile.
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maintain the functional stability of the frameshift stem-loop,
P1:pro has an arginine-to-glycine mutation instead of the
arginine-to-lysine mutation used in SLP1TF. The estimated
stability of the P1:pro stem-loop (16.9 kcal/mol) was simi-
lar to that of SLP1TF (16.2 kcal/mol), which replicates at
wild-type levels. In addition, one residue (lysine 12) of TF was
altered; since this residue is also altered in SLP1TF, it is
unlikely that this will influence viral function.
The cellular protein pattern of P1:pro was similar to that
of the wild type (Fig. 6A), while P1:pro showed a large
decrease in the level of p66-RT (Fig. 6A), similar to that seen
in SLP1TF (Fig. 3A). Purified viral particles were also ana-
lyzed by Western blotting. Compared to the wild-type virion
profile, the P1:pro mutant displayed a slight increase in the
level of Pr-55 Gag while the P1:pro mutant displayed large
decreases in the levels of p66-RT and p51-RT and an increased
level of p55-Gag relative to the level of p24-CA (Fig. 6B).
Again these differences in protein profile for P1:pro were
consistent with those observed for SLP1TF (Fig 3B). Virion
genomic RNA analyses demonstrated that RNA was present in
both mutants and that the stability of the P1:pro dimeric
RNA was comparable to that of the wild type, while the P1:
pro dimeric RNA stability was dramatically reduced (Fig.
6C), resembling the stability of RNA dimers observed for
SLP1TF (Fig. 4). The P1:pro mutant replicate in PBMCs at
a low level compared to wild-type, while the P1:pro mutant
was noninfectious (Fig. 6D).
DISCUSSION
Within the frameshift region of HIV-1, the critical RNA
secondary structures of the frameshift stem-loop, the Gag
spacer peptide p1, and the GagProPol protein TF overlap. To
characterize the frameshift region of HIV-1, we have created a
series of mutants that systematically alter the stem-loop, p1,
and TF. Changes to the stability of the frameshift stem-loop
have demonstrated the importance of stem-loop thermody-
namic stability in maintaining the optimal frameshifting effi-
ciency required for viral infectivity. In addition, we provide the
first evidence that the HIV-1 spacer peptide p1, and in partic-
FIG. 3. Impact of frameshift region mutations on HIV-1 protein profiles as determined by Western blot analysis. Cell (A) and virion (B) lysates
were produced from transfections in 293T cells, resolved by SDS-polyacrylamide gel electrophoresis (10% polyacrylamide), and probed with sera
from HIV-1-infected individuals. Lanes 1 show the wild-type (SLP1TF) HIV-1 protein profiles.
FIG. 4. Effect of frameshift region mutants on virion RNA dimerization. The impact of the frameshift region mutants on genomic RNA
dimerization was determined using melting-curve and electrophoretic analysis of wild-type and mutant RNA. Virion RNA was resuspended in
RNA dimerization buffer and heat denatured for 10 min at the indicated temperatures. Dimers and monomers were electrophoresed in a 1% native
agarose gel and probed with an HIV-1 riboprobe. RT, room temperature.
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ular the two proline residues of p1, are important for HIV-1
replication.
Two types of mutants were initially utilized in this study,
those with very slight changes in stem-loop stability, which
aimed to maintain frameshifting efficiency at wild-type levels,
and those with a more dramatic decrease in stem-loop stability.
Reduction of stem-loop stability by an estimated G of 4–5
kcal/mol1 (SLP1TF and SLP1TF) did not discernibly affect
the translation efficiency of GagProPol, since the levels of
GagProPol produced in the protease-negative constructs were
comparable to those in the wild type. Moreover, one of the two
mutants, SLP1TF, replicated as well as did wild-type virus in
PBMCs. Taken together, these results most probably reflect
the ability of the HIV-1 frameshift stem-loop to accommodate
minor alterations to stability and maintain the balance between
structural proteins and enzymes that is required for the pro-
duction of infectious virion. This observation is consistent with
the variability in frameshift stem-loop stability found in differ-
ent strains and subtypes of HIV-1 (7) and with the results of a
recent study by Telenti et al. demonstrating that natural vari-
ations in thermodynamic stability that resulted in decreased
frameshifting and impaired GagProPol maturation were still
able to support wild-type replication (39). Large reductions in
stem-loop stability (an estimated G of 14 to 15 kcal/mol1)
in mutants SLP1TF and SLP1TF resulted in a marked
decrease in GagProPol synthesis. The reduced level of Gag-
ProPol in SLP1TF and SLP1TF was, however, sufficient to
support protease activity, since processed products were ob-
served in virion particles. Mutants with major disruptions to
stem-loop stability (SLP1TF and SLP1TF) were found to
be noninfectious in PBMCs. The decreased stem-loop stability
of the SL mutants did not affect the ability of these virions to
package dimeric RNA and had little effect on genomic RNA
dimer stability, with SLP1TF having a dimer stability similar
to that of the wild type.
TF is important for the activation and regulation of PR
activity (1, 25, 30, 31, 41, 43, 44). In this study, mutations to the
amino acid sequence of TF (SLP1TF) generated virions sim-
ilar in profile to the wild-type virus. TF has two domains, TFP
and P6Pol (4, 25). TFP is a highly conserved octapeptide that is
a specific competitive inhibitor of the mature PR (25). In
SLP1TF, only one amino acid in the TFP region was altered
(phenylalanine to valine at position 8), which may not be suf-
ficient to disrupt TFP function. The remaining changes were in
the amino-acid-variable region of P6Pol, which has been sug-
gested to be an unstructured protein whose importance lies in
its ability to create a stable space between nucleocapsid (NC)
and PR (2).
This study provides the first evidence that the spacer peptide
p1 sequence is important for HIV-1 replication. The SLP1TF
mutant, which includes six amino acid changes in the 16-ami-
no-acid p1 sequence, had altered protein processing, reduced
RNA dimer stability, and was noninfectious in PBMCs. Two
additional p1 mutants were analyzed: P1:pro has the two
highly conserved proline residues of p1 replaced by leucines,
while P1:pro was designed to closely emulate the SLP1TF
mutations while keeping the two proline residues intact. Anal-
ysis of the P1:pro mutant revealed defects in protein pro-
cessing and RNA dimer stability similar to those observed for
SLP1TF. The P1:pro mutant, however, showed protein pat-
terns comparable to those of the wild type and also showed
unchanged genomic RNA dimer stability. In addition, while
P1:pro was noninfectious in PBMCs, P1:pro displayed a
low level of PBMC infection. These results further demon-
strate that p1 is important for viral replication. Since the rigid
cyclic structure of proline can confer unique conformational
constraints on a peptide, dramatically affecting protein archi-
tecture, these results suggest that the proper folding of the p1
protein may be critical for HIV-1 replication. The fact that the
P1:pro mutant was less infectious than the wild type suggests
that p1 amino acids other than proline may also contribute to
HIV-1 replication.
Western analysis of SLP1TF and P1:pro showed an al-
teration to the wild-type cellular and virion protein patterns
that most dramatically included a reduction in the amount of
RT protein. In addition, the virion profile of P1:pro dis-
played a large increase in the level of unprocessed Pr55-Gag.
Taken together, these results suggest that the conformation of
p1 may influence protein processing. Genomic RNA dimer
stability and defects in proteolytic processing appear to be
FIG. 5. Replication of the frameshift region mutants in PBMCs. Freshly isolated PBMCs were phytohemagglutinin stimulated for 3 days and
then infected with either wild-type (SLP1TF) or mutant virion. Infectivity was monitored as RT activity in the culture supernatants, which were
collected 3, 7, 10, and 14 days postinfection. The results shown represent the mean and standard deviation of duplicate samples.
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linked, since RNA dimers from PR-defective HIV-1 are less heat
stable than dimers from wild-type HIV-1 (13). Stabilization of
genomic RNA dimers is under the control of the mature
NC, and it has recently been shown that p2/NC cleavage site
mutants disrupt genomic RNA dimer stability and that cleav-
age of P2/NC in Gag is more important than in GagProPol for
maintaining dimer stability (36). Even subtle changes to Gag
processing in SLP1TF and P1:pro that delay the cleavage of
p2/NC may be sufficient to result in the decrease of RNA
dimer stability observed in these p1 mutants. Interestingly,
SLP1TF genomic RNA dimers were stable at temperatures
up to 5°C higher than for those of SLP1TF. This result could
FIG. 6. (A) Impact of frameshift region mutations on HIV-1 protein profiles as determined by Western blot analysis for cell (left) and virion
lysates (right) that were probed with sera from HIV-1-infected individuals. (B) Effect of frameshift region mutants on virion RNA dimerization.
(C) Replication of the p1 mutants in PBMCs. Infectivity was monitored as RT activity in the culture supernatants, which were collected 3, 7, 10,
and 14 days postinfection. The results shown represent the mean and standard deviation of duplicate samples.
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represent a difference in the nature of the p1 amino acid
mutations, or, alternatively, it may be that the effect of the
stem-loop mutations override any functions specific to p1.
Any structural requirement for the p1 proline residues is
likely to be transient, possibly influencing the arrangement of
the Pr55-Gag precursor protein to yield the correct positioning
for initiating or mediating proteolytic processing during HIV
assembly. Since p1 forms part of p15-NC (NC-P1-P6), which
specifically binds RNA and is tightly linked to the dimeric
RNA genome and RT to form the ribonucleoprotein complex
(9), modification of the protein configuration as a result of the
proline mutations in SLP1TF and P1:pro could alter the
role of p15-NC, affecting genomic RNA dimerization and core
formation. In addition, the importance of p1 proline residues
in HIV replication may be due in part to their role in the
overall protein folding in the proline-rich P1-P6 C terminus of
Gag. Further investigation is required to explore whether p1
conformation is important for the function of the p55-Gag
precursor protein or an intermediate such as p15-NC or if in
fact p1-p6 acts as a single domain during the process of HIV-1
assembly.
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